A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

3D GraftRasp System Including Spine Indications Receives FDA 510(k) Clearance – Approved for General Orthopedic Use and Spine Proccedures

October 1, 2020

3D GraftRasp System, as well as spine indications, has received U.S. Food and Drug Administration (FDA) 510(k) clearance. The news was announced today by SurGenTec.

The 3D GraftRasp System is the only device to receive FDA clearance that allows for both decortication of bone and the delivery of autograft, allograft or synthetic bone graft. It is approved for general orthopedic use and spine procedures. “In spine procedures, the transverse processes and facet joints may now be targeted in a more efficient and effective surgical technique pioneered by SurGenTec,” says Founder and CEO Travis Greenhalgh. The 3D GraftRasp System is ideal for use in posterolateral or intertransverse lumbar fusion cases.

Posterolateral fusion has long been a standard of care to treat lumbar spine disorders and remains one of the most commonly performed procedures. In open posterolateral lumbar fusion surgery, the transverse processes and facet joints are routinely decorticated and bone graft is packed in lateral trench-like gutters to help achieve fusion. In minimally invasive cases, this region is typically neglected due to challenges accessing the anatomy. SurGenTec’s new 3D GraftRasp System allows physicians to easily access the anatomy while making less invasive incisions and offering the same standard of care as with an open lumbar fusion.

The 3D GraftRasp system features instruments including straight or curved rasps, specific to the surgical site anatomy. The rasps feature disposable foot plates with conical teeth that help to ensure optimal decortication. 3D GraftRasp is intended to be used in conjunction with the GraftGun® delivery system to facilitate controlled bone graft delivery to the surgical site. Autograft, allograft or synthetic bone graft is extruded with accuracy through an aperture in the rasp directly to the decorticated area, which instills confidence that bone graft is placed precisely where fusion is desired.

The 3D GraftRasp System was designed for synergy between the GraftRasp instrument and GraftGun. For ease of use and saving time the GraftGun tubes are pre-loaded with OsteoFlo® NanoPutty®(Synthetic), ViMax® fiber cellular matrix, or Ossify™ DBM putty and Ossify™ cortical fibers. The universal GraftGun kit may also be utilized to allow surgeons the freedom to load the bone graft of their choice.

“FDA clearance of the 3D GraftRasp System expands our treatment modalities in the spine market. This is an exciting time for our company and for physicians who need intuitive instruments to treat their patients,” said Andrew Shoup, SurGenTec’s COO. SurGenTec is currently launching several unique product lines focused on physician needs and the 3D GraftRasp System fills a void in spine surgery that’s been overlooked for years. “Physicians want efficiency and better outcomes, while patients want a better chance to resume a lifestyle that makes them happy and pain free,” said Shoup.

The 3D GraftRasp System is protected by more than 10 patents with more applications pending. SurGenTec plans to release iterations for other general orthopedic uses such as large-joint and the foot/ankle markets. The company is releasing the 3D GraftRasp System immediately and will be hosting physician training sessions in its new BioSkills Lab in Boca Raton, FL. The company has the ability to host live wet-lab training sessions or physicians may attend remotely via video conference.

SourceSurGenTec
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy